Chapter 473: Chapter 274: CCTV Steps In, Support from the Liver Oncology Community

You have to support your own!

After so many years of relentlessly catching up in the medical technology industry, the experts and professors who formed the backbone of Jin Country had long since built up the energy and courage to vie for the top spot.

They were only missing a catalyst. This time, Wu Ting’s team’s project gave them the perfect outlet.

They weren’t just supporting Wu Ting; they were making a stand for the honor of Jin Country’s entire medical and health industry.

Times had changed. Jin Country’s scientists and researchers marched relentlessly onward, indomitable in their pursuit of scientific truth, constantly pushing humanity to new technological heights.

Many of Jin Country’s major scientific achievements were leading the world. In the past few years, Jin Country had made significant breakthroughs in quantum computing, becoming the only nation to demonstrate quantum superiority in two different physical systems...

The "Sky Eye" of Jin Country was officially opened to the world, a demonstration of the nation’s magnanimity...

The artificial synthesis of starch from carbon dioxide, offering brand-new possibilities for the future of humanity...

Colonel Li Ai’s strategic laser weapon, equally inspiring...

Hualong One, Jin Country’s independently designed and constructed third-generation nuclear power technology...

...

...

So, in the field of primary liver cancer related to hepatitis B, why shouldn’t they dare to take the lead ahead of all other teams?

The International Liver Cancer Association was just an international organization, after all. Was their authorization, their approval, their attempt to co-opt us really that important?

We, Jin Country, could also lead the way. We dared to, and we were more than capable of pioneering the technology to completely cure primary liver cancer!

One after another, the hepatic tumor research center received applications from over sixty teams across the country, all willing to throw their full support behind the advancement of Wu Ting’s research project.

Those with the facilities, technology, and resources applied to bring in the relevant equipment and techniques.

Those without such resources were willing to dispatch their surgical teams to join the pilot hospitals for advanced training, contributing their personnel to the effort.

Wu Ting, Fu Jinfen, Chen Bofeng, Ma Shengzhong, and Jin Yu had never expected to receive such overwhelming support from the domestic hepatic oncology community.

Everyone was deeply moved and full of anticipation.

During this time, many patients had been discharged after undergoing Wu Ting’s three-stage treatment. Their post-operative indicators and follow-up results were all excellent, which gave the teams a huge boost in confidence.

The initial teams began contacting the leaders of the second batch of groups that had joined. The process was the same: they would first come to the hepatic tumor research center for intensive training, and after passing an assessment, they could begin the clinical rollout.

Like a single spark starting a prairie fire, Wu Ting’s team’s treatment technology spread out from its base in the Yangtze River Delta, radiating out to hospitals across all of Jin Country!

In the wake of this international incident, Scholar Zeng Jiu, the president of the Qinghe City Medical Association’s Hepatic Tumor Division, and the high-ranking officials at the Jin Country Ministry of Health opted for tacit approval.

There was no explicit support, but there wasn’t the slightest hint of opposition either!

Scholar Zeng, in particular, chose to completely ignore the pressure from the International Liver Cancer Association.

It was said that Scholar Zeng had gone away to recuperate for a while!

...

...

Wu Ting briefly returned to Fan City. After arranging the research in the hepatic tumor field, he was scheduled to head to Fuwai for intensive training in cardiac surgery.

While Wu Ting was at City First Hospital’s Department of Hepatic Tumor Surgery, he received two unexpected phone calls.

One was from Ford, the Vice President of GSK.

The other was from Steve, the Vice President of the Johnson & Johnson Group.

The two men had made a special trip to Jin Province, and after contacting Wu Ting, they came directly to Fan City First Hospital.

Upon arriving in Jin Province, they immediately learned of Wu Ting’s perfect performance in the national cardiac surgery competition. They had originally come for Wu Ting’s fourth-generation bioresorbable polymer vascular stent and his controllable, self-expanding valve delivery system.

They hadn’t expected that Wu Ting would go on to refine and codify the Hybrid Technology right in the finals.

This showed the two vice presidents his immense potential. If Wu Ting joined the project team at Fuwai and truly managed to establish an expert consensus and clinical guidelines for Hybrid Technology...

...that would trigger a massive revolution in cardiac surgery. Aortic disease was a major component of cardiovascular illness, representing a market worth hundreds of billions.

This included related medical devices, diagnostic equipment, and a host of commonly used therapeutic drugs.

If Wu Ting could establish the guidelines, he would have the power and authority to recommend specific drugs, devices, and equipment. This involved a massive web of vested interests.

This symbiotic exchange of interests was precisely why top pharmaceutical giants like Johnson & Johnson and GSK, and other major capital groups, funded international associations and supported the leading figures in medicine.

Consider two drugs with similar functions: one is recommended by an international association and included in industry guidelines, while the other is not. One can easily imagine the different fates awaiting those two drugs.

Steve and Ford’s targets were the Southern Continent market and the Mizhou market, respectively, allowing for a mutually beneficial partnership. Their common rival was Ruihui and the medical authorities allied with them.

When Steve and Ford saw Wu Ting’s public declaration of war on Headquarter TV Station, followed by the outpouring of support from one hospital after another in the domestic hepatic tumor field, they were utterly astonished.

This time, they truly saw Wu Ting’s formidable influence and his potential to become a future leader in the industry.

The two vice presidents met beforehand and made a joint resolution: they would bet everything on Wu Ting!

Inside the deputy director’s office of the Department of Hepatic Tumor Surgery.

Wu Ting received the two heavyweights.

Wu Ting had previously met representatives from both pharmaceutical companies at the "Mount Hua Summit" for immunology and had exchanged contact information.

If you find any errors ( broken links, non-standard content, etc.. ), Please let us know < report chapter > so we can fix it as soon as possible.